pH7 strives to be a bastion of diligence and responsibility, setting high, technically proficient and new standards for plant-based medicines in the European Union.
Launched in 2022 our group aims to be the leading platform in pharmaceutical Cannabis distribution in Europe over the coming decade.
pH7 brings together patients and leading medical professionals from around the world to focus on new categories of medicine. Specifically, Individuals who are passionate about improving patients' quality of life via access to cannabis as a medicine.
Welcome to pH7, and welcome to the wellness of modernity.
The pH7 project was founded in 2022 by leading medical practitioners and Plant-based medicine ambassadors from across Europe and North America.
We noticed the area of Cannabis as a medicine in Europe was in its infancy and at this crucial moment could be steered in the right direction to deliver the best outcome for patients, doctors and society as a whole.
Through responsibility and diligence, we believe Cannabis is a fantastic addition to existing pharmaceutical medical knowledge and practices. We aspire to be bastions of this new domain of pharmaceuticals and we invite you to join us.